nodes	percent_of_prediction	percent_of_DWPC	metapath
Amcinonide—ANXA1—mammary gland—sarcoma	0.074	0.0919	CbGeAlD
Amcinonide—ANXA1—myometrium—sarcoma	0.0525	0.0652	CbGeAlD
Amcinonide—ANXA1—embryo—sarcoma	0.0505	0.0627	CbGeAlD
Amcinonide—ANXA1—seminal vesicle—sarcoma	0.0474	0.0589	CbGeAlD
Amcinonide—ANXA1—hematopoietic system—sarcoma	0.0451	0.056	CbGeAlD
Amcinonide—ANXA1—connective tissue—sarcoma	0.0434	0.0539	CbGeAlD
Amcinonide—ANXA1—smooth muscle tissue—sarcoma	0.0397	0.0493	CbGeAlD
Amcinonide—ANXA1—skin of body—sarcoma	0.0392	0.0487	CbGeAlD
Amcinonide—ANXA1—cardiac atrium—sarcoma	0.0342	0.0425	CbGeAlD
Amcinonide—ANXA1—uterus—sarcoma	0.034	0.0423	CbGeAlD
Amcinonide—ANXA1—lymphoid tissue—sarcoma	0.0317	0.0394	CbGeAlD
Amcinonide—ANXA1—tendon—sarcoma	0.0298	0.0371	CbGeAlD
Amcinonide—ANXA1—bone marrow—sarcoma	0.0289	0.0359	CbGeAlD
Amcinonide—ANXA1—testis—sarcoma	0.0247	0.0307	CbGeAlD
Amcinonide—ANXA1—liver—sarcoma	0.0234	0.029	CbGeAlD
Amcinonide—NR3C1—myometrium—sarcoma	0.0182	0.0227	CbGeAlD
Amcinonide—ANXA1—lymph node—sarcoma	0.0179	0.0222	CbGeAlD
Amcinonide—NR3C1—embryo—sarcoma	0.0175	0.0218	CbGeAlD
Amcinonide—NR3C1—seminal vesicle—sarcoma	0.0165	0.0205	CbGeAlD
Amcinonide—NR3C1—hematopoietic system—sarcoma	0.0157	0.0195	CbGeAlD
Amcinonide—NR3C1—connective tissue—sarcoma	0.0151	0.0187	CbGeAlD
Amcinonide—NR3C1—smooth muscle tissue—sarcoma	0.0138	0.0171	CbGeAlD
Amcinonide—NR3C1—skin of body—sarcoma	0.0136	0.0169	CbGeAlD
Amcinonide—NR3C1—cardiac atrium—sarcoma	0.0119	0.0148	CbGeAlD
Amcinonide—NR3C1—uterus—sarcoma	0.0118	0.0147	CbGeAlD
Amcinonide—NR3C1—lymphoid tissue—sarcoma	0.011	0.0137	CbGeAlD
Amcinonide—NR3C1—tendon—sarcoma	0.0104	0.0129	CbGeAlD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—sarcoma	0.0101	0.0516	CbGpPWpGaD
Amcinonide—NR3C1—bone marrow—sarcoma	0.01	0.0125	CbGeAlD
Amcinonide—NR3C1—testis—sarcoma	0.00858	0.0107	CbGeAlD
Amcinonide—NR3C1—liver—sarcoma	0.00811	0.0101	CbGeAlD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.00695	0.0356	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.00669	0.0343	CbGpPWpGaD
Amcinonide—NR3C1—lymph node—sarcoma	0.00622	0.00773	CbGeAlD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.00607	0.0311	CbGpPWpGaD
Amcinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—sarcoma	0.00545	0.0279	CbGpPWpGaD
Amcinonide—ANXA1—Peptide ligand-binding receptors—CXCR4—sarcoma	0.0051	0.0262	CbGpPWpGaD
Amcinonide—NR3C1—Transcription factor regulation in adipogenesis—CREB1—sarcoma	0.00485	0.0249	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00469	0.0241	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.00453	0.0232	CbGpPWpGaD
Amcinonide—ANXA1—G alpha (i) signalling events—CXCR4—sarcoma	0.00431	0.0221	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.00369	0.0189	CbGpPWpGaD
Amcinonide—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00342	0.0175	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—FOXO1—sarcoma	0.00331	0.017	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.00329	0.0168	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—IL2—sarcoma	0.00296	0.0152	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—CCND1—sarcoma	0.00288	0.0148	CbGpPWpGaD
Amcinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.00278	0.0143	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.00272	0.014	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.00272	0.0139	CbGpPWpGaD
Amcinonide—ANXA1—GPCR ligand binding—CXCR4—sarcoma	0.00261	0.0134	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	0.00248	0.0127	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.00237	0.0121	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.00236	0.0121	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.00236	0.0121	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.00235	0.012	CbGpPWpGaD
Amcinonide—NR3C1—Circadian Clock—CREB1—sarcoma	0.00233	0.0119	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—MYC—sarcoma	0.00231	0.0119	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—EGFR—sarcoma	0.00226	0.0116	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00225	0.0115	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.00206	0.0106	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—MDM2—sarcoma	0.00199	0.0102	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.00196	0.0101	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.00196	0.01	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.00194	0.00996	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CREB1—sarcoma	0.00192	0.00985	CbGpPWpGaD
Amcinonide—ANXA1—Spinal Cord Injury—TP53—sarcoma	0.0019	0.00974	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.0019	0.00974	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.00186	0.00952	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.00176	0.009	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.00176	0.009	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—JUN—sarcoma	0.00173	0.00885	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.00171	0.00877	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.00171	0.00876	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	0.00169	0.00867	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—FOXO1—sarcoma	0.00161	0.00827	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.00157	0.00807	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.00156	0.008	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of Androgen receptor activity—SRC—sarcoma	0.00155	0.00793	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.00154	0.00789	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	0.00154	0.00788	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—CXCR4—sarcoma	0.00147	0.00755	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.00145	0.00745	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—IL2—sarcoma	0.00142	0.00728	CbGpPWpGaD
Amcinonide—NR3C1—Endoderm Differentiation—CTNNB1—sarcoma	0.0014	0.00719	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	0.0014	0.00718	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.0014	0.00718	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CCND1—sarcoma	0.00138	0.0071	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—JUN—sarcoma	0.00138	0.00708	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—CTNNB1—sarcoma	0.00137	0.00703	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CXCR4—sarcoma	0.00134	0.00686	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	0.00132	0.00678	CbGpPWpGaD
Amcinonide—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.00129	0.00662	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.00125	0.00641	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TLE1—sarcoma	0.00124	0.00636	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.00123	0.0063	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.00122	0.00624	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CREB1—sarcoma	0.00117	0.006	CbGpPWpGaD
Amcinonide—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	0.00112	0.00576	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—MYC—sarcoma	0.00111	0.00569	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFC—sarcoma	0.00105	0.00537	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	0.00101	0.00519	CbGpPWpGaD
Amcinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000988	0.00506	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—FUS—sarcoma	0.000915	0.00469	CbGpPWpGaD
Amcinonide—NR3C1—AP-1 transcription factor network—TP53—sarcoma	0.000912	0.00467	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FLT1—sarcoma	0.000837	0.00429	CbGpPWpGaD
Amcinonide—NR3C1—Adipogenesis—CTNNB1—sarcoma	0.000835	0.00428	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PLCG1—sarcoma	0.000823	0.00422	CbGpPWpGaD
Amcinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	0.000803	0.00412	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CXCR4—sarcoma	0.00079	0.00405	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—ATF1—sarcoma	0.000782	0.00401	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	0.000728	0.00373	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000722	0.0037	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—CREB1—sarcoma	0.000717	0.00367	CbGpPWpGaD
Amcinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000636	0.00326	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IGF1R—sarcoma	0.000613	0.00314	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—FOXO1—sarcoma	0.000584	0.00299	CbGpPWpGaD
Amcinonide—ANXA1—GPCR downstream signaling—IL2—sarcoma	0.000583	0.00299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFRB—sarcoma	0.000583	0.00299	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—PDGFRA—sarcoma	0.000574	0.00294	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—IL2—sarcoma	0.00053	0.00272	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KDR—sarcoma	0.000483	0.00247	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KIT—sarcoma	0.000445	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—NRAS—sarcoma	0.000445	0.00228	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CREB1—sarcoma	0.000423	0.00217	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—EGFR—sarcoma	0.000405	0.00208	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—KRAS—sarcoma	0.000383	0.00196	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MDM2—sarcoma	0.00035	0.0018	CbGpPWpGaD
Amcinonide—ANXA1—Signaling by GPCR—HRAS—sarcoma	0.000325	0.00167	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—IL2—sarcoma	0.000313	0.0016	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CCND1—sarcoma	0.000305	0.00156	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—JUN—sarcoma	0.000304	0.00156	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—CTNNB1—sarcoma	0.000302	0.00155	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—SRC—sarcoma	0.000273	0.0014	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—VEGFA—sarcoma	0.000266	0.00136	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—NRAS—sarcoma	0.000263	0.00135	CbGpPWpGaD
Amcinonide—NR3C1—Generic Transcription Pathway—MYC—sarcoma	0.000247	0.00127	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—MYC—sarcoma	0.000245	0.00125	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—EGFR—sarcoma	0.000239	0.00123	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—KRAS—sarcoma	0.000226	0.00116	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—TP53—sarcoma	0.000201	0.00103	CbGpPWpGaD
Amcinonide—ANXA1—Signaling Pathways—HRAS—sarcoma	0.000192	0.000985	CbGpPWpGaD
Amcinonide—NR3C1—Gene Expression—MYC—sarcoma	0.000119	0.00061	CbGpPWpGaD
